| 1 (15) | F Hoffmann-La Roche * | MUL |  |
| 2 (22) | Merck * | MUL | |
| 3 (25) | AstraZeneca * | MUL | |
| 4 (28) | Hoffmann-La Roche Ltd, United States | USA | |
| 5 (31) | GlaxoSmithKline * | MUL | |
| 6 (32) | Pfizer * | MUL | |
| 7 (34) | Merck & Co Inc, United States | USA | |
| 8 (40) | Genentech Inc | USA | |
| 9 (42) | Pfizer Inc, United States | USA | |
| 10 (50) | Samsung Corp * | MUL | |
| 11 (66) | Novartis * | MUL | |
| 12 (67) | IBM United States | USA | |
| 13 (99) | Johnson & Johnson * | MUL | |
| 14 (108) | Bristol-Myers Squibb Company * | MUL | |
| 15 (110) | Bristol-Myers Squibb Company, United States | USA | |
| 16 (115) | GlaxoSmithKline, United States | USA | |
| 17 (118) | Janssen | MUL | |
| 18 (120) | Regeneron Pharmaceuticals Inc | USA | |
| 19 (132) | IBM Research * | MUL | |
| 20 (142) | Eli Lilly and Company, United States | USA | |
| 21 (146) | Eli Lilly * | MUL | |
| 22 (160) | Novartis Institutes for Biomedical Research, United States | USA | |
| 22 (160) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 24 (167) | AstraZeneca, United States | USA | |
| 25 (173) | AstraZeneca, United Kingdom | GBR | |
| 26 (183) | Takeda Pharmaceuticals International Inc * | MUL | |
| 27 (185) | Robert Bosch * | MUL | |
| 28 (187) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 29 (204) | Bayer * | MUL | |
| 30 (207) | Janssen Biotech Inc | USA | |
| 31 (210) | Celgene Corp | USA | |
| 32 (211) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 33 (212) | Bayer AG, Germany | DEU | |
| 34 (218) | Amgen, USA | USA | |
| 35 (219) | Amgen * | MUL | |
| 36 (222) | GlaxoSmithKline, United Kingdom | GBR | |
| 37 (229) | MedImmune, LLC. | USA | |
| 38 (236) | Mitsubishi Corp * | MUL | |
| 39 (240) | AstraZeneca, Sweden | SWE | |
| 40 (243) | Takeda Pharmaceuticals International Inc, USA | USA | |
| 41 (248) | AbbVie * | MUL | |
| 42 (250) | AbbVie Inc, United States | USA | |
| 43 (258) | Gilead Sciences * | MUL | |
| 44 (259) | Gilead Sciences Inc, United States | USA | |
| 45 (309) | Takeda Pharmaceutical Co Inc, Japan | JPN | |
| 46 (310) | Janssen Research & Development, LLC | BEL | |
| 47 (314) | Sanofi * | MUL | |
| 48 (324) | Sanofi, United States | USA | |
| 49 (334) | Boehringer Ingelheim * | MUL | |
| 50 (342) | Sumitomo Group * | MUL | |
| 51 (352) | Biogen Idec, USA | USA | |
| 52 (364) | Merck KGaA, Germany | DEU | |
| 53 (366) | Biogen Idec * | MUL | |
| 54 (404) | Unilever * | MUL | |
| 55 (424) | Syngenta * | MUL | |
| 56 (426) | Allergan plc * | MUL | |
| 56 (426) | Allergan plc, USA | USA | |
| 56 (426) | Astellas Pharma Inc | JPN | |
| 59 (434) | Novo Nordisk * | MUL | |
| 60 (445) | Novo Nordisk A/S | DNK | |
| 61 (450) | Unilever, United Kingdom | GBR | |
| 62 (454) | Daiichi Sankyo Co., Ltd. * | MUL | |
| 63 (461) | BASF Group * | MUL | |
| 64 (462) | BASF, Germany | DEU | |
| 65 (471) | GlaxoSmithKline, Belgium | BEL | |
| 66 (472) | Novartis, Switzerland | CHE | |
| 67 (480) | Boehringer Ingelheim GmbH Germany | DEU | |
| 68 (484) | Daiichi Sankyo Co., Ltd. Japan | JPN | |
| 69 (495) | General Electric Company * | MUL | |
| 70 (496) | Eli Lilly and Company Ltd., United Kingdom | GBR | |
| 71 (498) | DowDupont * | MUL | |
| 72 (538) | RTI Health Solutions | USA | |
| 73 (540) | UCB Pharma SA * | MUL | |
| 74 (542) | Novartis Pharmaceuticals, United States | USA | |
| 75 (546) | Pfizer Inc, United Kingdom | GBR | |
| 76 (564) | Procter & Gamble, USA | USA | |
| 77 (568) | Translational Research Institute | AUS | |
| 78 (580) | Boehringer Ingelheim, USA | USA | |
| 78 (580) | Shionogi & Co Ltd | JPN | |
| 80 (581) | Manipal Global Education Group * | MUL | |
| 81 (590) | Procter & Gamble Co * | MUL | |
| 82 (594) | Bayer Corp, USA | USA | |
| 83 (621) | UCB Pharma SA, Brussels | BEL | |
| 84 (676) | Sumitomo Chemical Co Ltd | MUL | |
| 85 (680) | Mitsubishi Chemical Holdings Corp | MUL | |
| 86 (704) | Dow Chemical Co USA | USA | |
| 87 (705) | Dow Chemical Co | MUL | |
| 88 (719) | Syngenta, United Kingdom | GBR | |
| 89 (768) | Agilent Technologies * | MUL | |
| 90 (791) | China State Institute of Pharmaceutical Industry | CHN | |
| 91 (867) | Pharmaceutical Product Development LLC | USA | |
| 92 (868) | Johnson & Johnson, United States | USA | |
| 93 (886) | Nestle Switzerland | CHE | |
| 94 (902) | Corteva | MUL | |
| 95 (904) | Nestle * | MUL | |
| 96 (911) | Corteva, USA | USA | |
| 97 (1006) | EMMES Corp | USA | |
|
